Cardiometabolic Articles & Analysis
6 articles found
As part of our quick fire questions series – or QFQs – we spoke to Dr. Andy Franklyn-Miller, Chief Medical and Innovation Officer at Nuritas about intelligent ingredients, explaining peptides and proving an AI model in life science. There is a lack of innovation within ingredients in food, many have been discovered decades ago, mostly with cost, taste and texture in mind. However as ...
Nuritas has recently published the results of two clinical studies on their next-generation ingredient PeptiStong™. Identified within fava beans, with self-affirmed GRAS and Health Canada approval, Peptistrong™ contains cell-signalling peptides which, when compared against milk proteins, were found to improve the rate of muscle protein synthesis during recovery. In this New Protein ...
Thus, there exists a major unmet medical need for novel therapeutic treatments for MetS, ultimately preventing the development of cardiometabolic-related morbidity and mortality. Currently, there are two main approaches under investigation for alleviating MetS progression (24). ...
Transfer of lipopolysaccharide from gram-negative bacteria into the systemic circulation of the body leads to the development of endotoxemia, which is detected in cardiometabolic diseases such as cardiovascular disease and obesity in addition to acute infections. ...
Abstract Background/objectives: Various adipose tissue compartments play an important role in the development of cardiometabolic diseases. The quantity of different fat compartments is influenced by genetic and environmental factors. ...
Abstract The heritability of coronary atherosclerotic plaque burden, coronary geometry, and phenotypes associated with increased cardiometabolic risk are largely unknown. The primary aim of the Burden of Atherosclerotic Plaques Study in Twins-Genetic Loci and the Burden of Atherosclerotic Lesions (BUDAPEST-GLOBAL) study is to evaluate the influence of genetic and ...